ADC Therapeutics SA (ADCT) — Institutional Holders, Q2 2026 (page 2)

114 institutional investment managers reported a ADCT position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $86.7M. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 101 to 114. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

ADCT 13F holders ranked 101–114 of 114

Institutional investors reporting a position in ADC Therapeutics SA on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
Integrated Wealth Concepts#101 · 302 sh$323.00New
Essential Partners#102 · 260 sh$278.00+983.3%
SBI Securities , Ltd.#103 · 222 sh$238.00New
Farther Finance Advisors#104 · 197 sh$211.00New
IFP Advisors#105 · 140 sh$150.00+366.7%
ROTHSCHILD INVESTMENT#106 · 121 sh$129.00New
Allworth Financial#107 · 104 sh$112.00-11.1%
GROUP ONE TRADING, L.P.#108 · 100 sh$107.000.0%
GAMMA Investing#109 · 49 sh$52.00-93.3%
Clearstead Advisors#110 · 36 sh$39.00New
SJS Investment Consulting#111 · 32 sh$35.00New
HARBOUR INVESTMENTS#112 · 20 sh$21.000.0%
IFG Advisory#113 · 15 sh$16.00New
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#114 · 1,431 sh—-74.3%

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.